| 老年冠心病合并房颤患者行经皮冠状动脉介入治疗术后的抗栓治疗策略及安全性 |
| |
| 引用本文： | 吴青,高霏,赵迎新. 老年冠心病合并房颤患者行经皮冠状动脉介入治疗术后的抗栓治疗策略及安全性[J]. 世界临床药物, 2013, 0(12): 765-768,I0001-I0003 |
| |
| 作者姓名： | 吴青 高霏 赵迎新 |
| |
| 作者单位： | [1]解放军总医院干部诊疗科,北京100853 [2]首都医科大学安贞医院心内科,北京100029 |
| |
| 摘 要： | 不少老年心房颤动（简称房颤）合并冠心病患者需行冠脉介入治疗,然而其术后的抗栓治疗面临极大挑战,华法林联合抗血小板双联治疗所致出血危险增加,而停用华法林所致脑卒中发生率又显著升高,上述患者最佳抗栓治疗策略尚无定论。本文简要回顾近年房颤患者术后抗栓治疗的策略及安全性。
|
| 关 键 词： | 房颤 抗凝 经皮冠状动脉介入术（PCI） |
Advances of antithrombotic regime in patients with atrial fibrillation undergoing percutaneous coronary intervention |
| |
| WU Qing,GAO Fei,ZHAO Ying-xin. Advances of antithrombotic regime in patients with atrial fibrillation undergoing percutaneous coronary intervention[J]. WORLD CLINICAL DRUGS, 2013, 0(12): 765-768,I0001-I0003 |
| |
| Authors: | WU Qing GAO Fei ZHAO Ying-xin |
| |
| Affiliation: | 1. Department of Senior Health, General Hospital of PLA, Beij＇ing 100853; 2. Department of Cardiology, An Zhen Hospital, Capital Medical University, Anzhenli Avenue, Beijing 100029, China) |
| |
| Abstract: | Many atrial fibrillation patients combined with coronary heart disease（CAD） need interventional therapy. However, the most challenge is antithrombotic therapy after PCI. Warfarin plus dual antiplatelet therapy in patients with atrial fibrillation could increase bleeding complications, whereas withholding warfarin can increase the risk of stroke and thromboembolism. The optimal antithrombotic regime in this situation is still unknown. This review describes the advances of antithrombotic regime in patients with atrial fibrillation treated by percutaneous coronary intervention. |
| |
| Keywords: | atrial fibrillation antithrombotic regime percutaneous coronary intervention（PCI） |
| 本文献已被 维普 等数据库收录！ |
|
